McKesson Contracts With Small Manufacturers Will Set Stage For Big Pharma Fee-For-Service Talks
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler is implementing core distribution agreements for its smaller “tier four” manufacturing partners effective June 1. McKesson says it is encouraged by initial response to the transition.